Quality by Design Training in Tunisia

Build Quality into Every Product

This instructor-led QbD programme helps pharmaceutical and biopharmaceutical professionals in Tunisia build quality into products from the design stage. You learn to apply the Quality Target Product Profile, Critical Quality Attributes, risk assessment, Design of Experiments and the control strategy, all aligned to the ICH Q8, Q9, Q10 and Q11 guidelines.

Flexible

Duration

Live

Mode

Hours

13.3K+ already enrolled

4.1 (2330+ Reviews)

8 enrolled this week

13 viewing right now

Want to Train Your Team?

Master Quality by Design and Lead Excellence in Tunisia

Starts from

USD 395

What Is Quality by Design and Why It Matters in TunisiaA Science-Based Route to Better Medicines

Quality by Design Training in Tunisia is a practical programme that teaches pharmaceutical and biopharmaceutical professionals how to build quality into products from the development stage, rather than testing it in at the end. Quality by Design (QbD) is the systematic, science-based approach set out in the ICH Q8, Q9, Q10 and Q11 guidelines and increasingly expected by regulators such as the FDA and EMA.

The course suits formulation scientists, process development engineers, analytical scientists, quality assurance teams and regulatory affairs professionals across Tunisia's growing pharmaceutical sector. You learn the structured QbD toolkit, from the Quality Target Product Profile and Critical Quality Attributes through to risk assessment, Design of Experiments, the design space and the control strategy.

With Tunisian manufacturers exporting to more than 20 countries and upgrading facilities to European and WHO GMP standards, QbD skills are now central to winning and defending international product registrations. Build capability you can apply the very next day with Invensis Learning.

Key Highlightsof the Quality by Design Training Course

End-to-End Skill Development

Structured Quality by Design training in the Tunisia is designed to help learners understand QbD principles, regulatory frameworks, and pharmaceutical product development methodologies covered in the program
Course content aligned with current ICH Q8, Q9, and Q10 guideline expectations, real-world pharmaceutical quality requirements, and practical learning objectives for Tunisia professionals delivered through a comprehensive Quality by Design training program
Real-world examples and scenario-based learning to help learners connect QbD concepts with everyday pharmaceutical development, manufacturing, and quality assurance situations
Guided learning support to help participants strengthen understanding, improve confidence, and apply QbD principles effectively across product development and manufacturing roles

Structured Courseware and Learning Resources

Access to organized QbD course materials including QTPP definition worksheets, CQA and CMA identification templates, CPP mapping guides, and DoE reference cards designed to support step-by-step learning
Topic-wise learning resources, exercises, and knowledge checks to reinforce understanding of Design Space, control strategies, and risk assessment tools
Practice activities, assignments, and scenario-based exercises to help learners apply QbD concepts in realistic pharmaceutical product development and manufacturing quality situations
Supplementary learning aids such as risk assessment matrices, Design Space configuration worksheets, RTRT implementation checklists, and control strategy development guides

Instructor-Led, Practical Learning Experience

Live interactive sessions delivered by experienced QbD practitioners with hands-on domain expertise across pharmaceutical, biotechnology, and manufacturing sectors
Real-world examples, case discussions, and applied QbD exercises to improve practical understanding of QTPP definition, CQA identification, DoE applications, and Design Space configuration
Opportunities to ask questions, clarify doubts, and participate in trainer-led discussions on risk assessment, CPP mapping, and regulatory compliance requirements
Training approach focused on helping learners apply QbD concepts confidently at work, not just complete the course content

Flexible Learning Support in Tunisia

Instructor-led training formats available for individual learners and corporate teams across the Tunisia
Options include live virtual classroom training, onsite training, and customized group training depending on availability and organizational requirements
Learning support designed to help participants stay on track before, during, and after the Quality by Design training
Additional revision and post-training support may be available based on the selected course format

Learn the Core Concepts Covered in the Course

Understand QbD fundamentals, background, key drivers, and the regulatory guidance documents including ICH Q8, Q9, and Q10 that shape modern pharmaceutical development
Learn how to define QTPP, identify CQAs, CMAs, and CPPs, apply DoE, configure Design Space, and develop control strategies based on the course curriculum
Explore practical use cases showing how QbD is applied in pharmaceutical, biotechnology, healthcare, and manufacturing environments
Build role-relevant knowledge of risk assessment and management, real-time release testing, and regulatory compliance that supports better quality decisions in product development

Practice, Assessment, and Completion Support

Practice defining QTPP, identifying CQAs and CMAs, mapping CPPs, and applying DoE through exercises and scenario-based activities
Use assessments to identify knowledge gaps in QbD concepts and strengthen understanding of Design Space and control strategy development
Receive guidance from instructors to improve understanding of QbD tools and stay aligned with course objectives
Earn a course completion certificate after successfully meeting the training requirements

Career and Workplace Application

Build practical QbD skills that can support career growth, role advancement, or improved pharmaceutical quality performance in the Tunisia
Strengthen confidence in applying QTPP definition, CQA identification, DoE, Design Space, and risk management concepts to real-world product development challenges
Improve professional credibility through structured, skill-focused Quality by Design training recognized across Tunisia pharmaceutical and manufacturing industries
Support enterprise capability building through Quality by Design corporate training for employees across pharmaceutical, biotechnology, healthcare, and manufacturing organizations.

Quality by Design Training Eligibility in the TunisiaWho Can Enroll?

No formal prerequisites are required to enroll in the Quality by Design training program
Basic familiarity with quality assurance concepts is helpful but not mandatory for enrollment
Professionals from pharmaceutical, biotechnology, healthcare, and manufacturing industries are well-suited for this training
Individuals and corporate teams seeking to build QbD knowledge and apply regulatory-aligned product development principles are eligible to enroll
Learners with backgrounds in quality, regulatory affairs, process engineering, and production management will find the content directly applicable to their roles

How QbD Skills Pay off in Your Daily WorkPractical Value for Individuals and Teams

For Individuals

QbD training helps pharmaceutical professionals move from empirical, trial-and-error development to a systematic, science-based approach. The course suits formulation scientists, process development engineers, analytical scientists, QA teams and regulatory affairs specialists who want to design quality in from the start. Whether you develop small molecule products, biologics or APIs, you gain practical tools you can use on live projects: the QTPP, CQA identification, risk assessment, Design of Experiments, the design space and the control strategy.

If you work in Tunisia's pharmaceutical or biopharmaceutical sector, QbD capability makes you far more effective at reducing deviations, defending submissions and supporting exports to European and African markets. The learning is immediately applicable and does not expire.

Apply QbD tools to real formulation and process work from day one
Build quality into products instead of relying on end-product testing
Lead QTPP and Critical Quality Attribute workshops with confidence
Run structured risk assessments using Ishikawa diagrams and FMEA
Plan Design of Experiments studies and interpret the resulting design space
Prepare stronger pharmaceutical development sections for regulatory submissions
Speak the shared QbD language that FDA and EMA reviewers expect
Stand out in Tunisia's export-focused pharmaceutical sector

For Organizations

QbD group training helps pharmaceutical organisations build development and quality capability by equipping cross-functional teams with a shared, structured approach. It can be delivered for formulation, process, analytical, QA and regulatory groups together. For Tunisian firms scaling exports and upgrading to European GMP standards, QbD provides a consistent language for building quality into products and defending it in regulatory submissions.

If your teams still set specifications empirically and rely on end-product testing, QbD training creates a common method for prioritising risk, running Design of Experiments and building a robust control strategy. That translates into fewer deviations, smoother scale-up and stronger submissions.

Standardise QbD practice across formulation, process and quality teams
Reduce manufacturing deviations through deeper process understanding
Build design spaces that lower the post-approval change burden
Strengthen CTD submissions to the FDA, EMA and African regulators
Support GMP upgrades and international export registrations
Develop cross-functional teams around one common QbD framework
Improve product consistency and patient safety
Tailor training to your live development projects

Your QbD Career Path in TunisiaRoles and Sectors Hiring Now

Quality by Design skills are increasingly sought across Tunisia's pharmaceutical and biopharmaceutical employers, from generic manufacturers and API producers to CDMOs and regulatory consultancies. As Tunisian firms export to more than 20 markets and upgrade to European GMP standards, professionals who can run QbD in development and manufacturing stand out. Quality by Design training equips them to step into exactly these roles. Demand spans formulation scientists, process development engineers, QA specialists and regulatory affairs leads, and here is what the market shows right now.

13,500+

Pharmaceutical sector direct jobs, Tunisia

FIPA Tunisia / industry, 2026

~39

Local pharmaceutical manufacturers

industry estimates, 2026

TND 68,000

QA / regulatory manager pay, Tunisia

average per year, worldsalaries / Paylab

~11.5% CAGR

Export growth to Sub-Saharan Africa

2026-2034 forecast, MarketIntelo

SECTORS HIRING

—Generic and Branded Pharmaceutical Manufacturing
—Biopharmaceuticals and Biosimilars
—Active Pharmaceutical Ingredient (API) Production
—Contract Development and Manufacturing (CDMOs)
—Regulatory Affairs and CMC Consulting
—Medical Devices and Veterinary Pharmaceuticals

GROWTH TRENDS

—Exports to 20+ countries driving GMP and QbD adoption
—Sector supplies over 60% of national medicine needs
—Around 39 manufacturers and 13,500+ direct jobs
—eCTD submissions mandatory from June 2026 under ANMPS
—Facility upgrades to European and WHO GMP standards
—AfCFTA opening new African export markets

Sources: FIPA Tunisia, MarketIntelo, Carthage Magazine, Paylab, worldsalaries.com (Tunisia) 2024-2026; ANMPS eCTD transition.

Designation

Quality by Design Professionals in Tunisia : Salary Insights and Trends

Hiring Companies in Tunisia

TND22K

Min

TND32K

Average

TND46K

Max

Paylab · SalaryExplorer (Tunisia)

AdwyaSIPHATCytopharma

Source: Adwya · SIPHAT · Cytopharma

Market Pressures Making QbD Essential in Tunisia

Export and GMP Compliance Pressure

Tunisian manufacturers export to over 20 countries and are upgrading to European and WHO GMP standards, where QbD-based development evidence is now expected in submissions.

QbD builds the development evidence exporters need

Regulatory Modernisation and eCTD

From June 2026, ANMPS requires eCTD submissions, and reviewers increasingly look for the QTPP, design space and control strategy detail that only a QbD approach delivers.

QbD supplies the QTPP, design space and control strategy detail

Shortage of Skilled Development Talent

The sector reports a shortage of staff skilled in modern pharmaceutical development, leaving many firms without the QbD capability that export markets now demand.

QbD training closes the capability gap

Legacy Quality-By-Testing Habits

Many teams still set specifications empirically and rely on end-product testing, causing avoidable deviations that QbD replaces with real, mechanistic process understanding.

QbD replaces testing-in with process understanding

Biopharma and Complex Products

Growth in biosimilars and complex generics raises quality risk, and QbD tools such as risk assessment and Design of Experiments are needed to control critical quality attributes.

QbD controls critical quality attributes in complex products

Cost and Value Pressure

Competitive generic pricing pushes firms to cut variability and rework, and QbD design spaces reduce post-approval changes and manufacturing failures across the product lifecycle.

QbD design spaces cut rework and change costs

Sources: FIPA Tunisia, Carthage Magazine, MarketIntelo, Market Access Africa (Tunisia pharma) 2025-2026; ANMPS eCTD transition.

QbD is more than a compliance box. It is the capability Tunisia's pharmaceutical sector needs to compete on exports and quality. Build practical QbD skills your teams can apply immediately. Start your journey today.

Your Tunisia QbD Career Shift

From Testing Quality to Designing It In,

The Shift QbD Delivers for Your Career

Tunisia's pharmaceutical sector is scaling exports and upgrading to European GMP standards, and employers increasingly separate professionals who can design quality in from those who only test for it. Here is which side of that line QbD training puts you on.

Today

Progress depends on years served, not a modern QbD skill set

After QbD

Skills that Tunisian and export-focused employers actively look for

Today

Progress depends on years served, not a modern QbD skill set

Today

Limited to end-product testing and firefighting deviations

After QbD

Able to design quality in and prevent deviations at source

Today

Limited to end-product testing and firefighting deviations

Today

Pay tied to a general QA or laboratory role

After QbD

Positioned for QA manager and CMC roles that pay toward TND 68,000

Today

Pay tied to a general QA or laboratory role

You Master QbD

Before

Quality is checked at the end and problems surface late

Now you have

A structured QbD toolkit that builds quality in from the design stage

Before

Quality is checked at the end and problems surface late

Before

Risk assessment is informal and rarely documented

Now you have

Formal Ishikawa and FMEA methods that focus development effort

Before

Risk assessment is informal and rarely documented

Before

Process limits are set by trial and error

Now you have

A DoE-based design space with proven acceptable ranges

Before

Process limits are set by trial and error

Before

Submissions rely on end-product testing data alone

Now you have

CTD pharmaceutical development sections built on QbD evidence

Before

Submissions rely on end-product testing data alone

"The gap between testing quality and designing it in is what separates the teams that win export registrations from those that do not."

Join 50,000+ professionals who trained with Invensis Learning and built practical skills.

Sources: Paylab, worldsalaries.com, FIPA Tunisia 2024-2026.

Module 1: Introduction to QbD

Background and key drivers that led to the adoption of Quality by Design in pharmaceutical development
Regulatory guidance documents including ICH Q8, Q9, and Q10 that define the QbD framework
QbD development process flow from concept and design through to manufacturing and regulatory submission

Module 2: QbD Tools and Techniques

Risk management principles and tools used to identify, assess, and control quality risks in product development
Design of Experiments (DoE): fundamentals, design types, and how DoE is used to understand process variability
Design Space definition and control strategies: how boundaries are established and maintained throughout the product lifecycle

Module 3: Industry and Regulatory Perspective

Regulatory framework for QbD including agency expectations from the FDA, EMA, and ICH guidelines
Implementation challenges organizations face when transitioning from traditional to QbD-based development approaches
Real-world industry examples demonstrating how pharmaceutical and biotechnology organizations have adopted QbD

Module 4: Quality Target Product Profile (QTPP)

Definition of the Quality Target Product Profile and its role in guiding QbD-based product development decisions
How QTPP links patient needs and regulatory requirements to specific product quality attributes and design objectives
Practical steps for defining a QTPP for pharmaceutical and biotechnology products

Module 5: Critical Quality Attributes, Critical Material Attributes, and Critical Process Parameters

Identifying Critical Quality Attributes (CQAs): what they are, how to define them, and why they are central to QbD
Critical Material Attributes (CMAs): how raw material properties influence product quality and must be controlled
Critical Process Parameters (CPPs): identifying process parameters that impact CQAs and require monitoring and control

Module 6: Statistical Design of Experiments

Fundamentals of statistical DoE including full factorial, fractional factorial, and response surface methodologies
Applications of DoE in pharmaceutical process development and optimization
Interpreting DoE results to establish design space boundaries and process understanding

Module 7: Design Space and Process Control

Design Space concept: defining the multidimensional combination of input variables and process parameters that provide quality assurance
Implementation of Design Space within regulatory submissions and manufacturing control strategies
Continuous process verification and how Design Space supports process control across the product lifecycle

Module 8: Risk Assessment and Management

Risk assessment methodologies used in QbD including FMEA, Ishikawa diagrams, and risk ranking tools
Applying risk management principles to product development decisions, process design, and control strategy development
Linking risk assessment outcomes to Design Space boundaries and CQA control strategies

Module 9: Real-time Release Testing (RTRT)

RTRT concept: replacing end-product testing with in-process monitoring and real-time quality assurance
Regulatory requirements and industry expectations for RTRT implementation in pharmaceutical manufacturing
Practical considerations for implementing RTRT as part of a QbD-based control strategy

Module 10: Case Studies and Practical Applications

Pharmaceutical and biotechnology case studies demonstrating end-to-end QbD implementation from QTPP to RTRT
Practical group exercises and scenario analysis applying QbD tools including QTPP definition, CQA identification, DoE, and risk assessment
Lessons learned and best practices from real QbD projects in pharmaceutical, biotechnology, and manufacturing environments

Course Curriculumof the Quality by Design Training

The online Quality by Design training course curriculum in the Tunisia is structured across ten modules, taking learners from foundational QbD background and regulatory guidance through to real-world case studies and practical applications in pharmaceutical, biotechnology, and manufacturing environments.

100% Secure and Safe download

Background and key drivers that led to the adoption of Quality by Design in pharmaceutical development
Regulatory guidance documents including ICH Q8, Q9, and Q10 that define the QbD framework
QbD development process flow from concept and design through to manufacturing and regulatory submission

Shifts your thinking from testing quality in at the end to designing it in from the start.

Module 1: Introduction to QbD

Background and key drivers that led to the adoption of Quality by Design in pharmaceutical development
Regulatory guidance documents including ICH Q8, Q9, and Q10 that define the QbD framework
QbD development process flow from concept and design through to manufacturing and regulatory submission

Shifts your thinking from testing quality in at the end to designing it in from the start.

100% Secure and Safe download

The QbD Skills You Will BuildTools You Apply on Real Projects

By the end of this QbD programme you will be able to apply the full Quality by Design toolkit to real pharmaceutical development work. The course builds practical capability across the QTPP, Critical Quality Attributes, risk assessment, Design of Experiments, the design space, PAT and the control strategy, aligned to the ICH Q8, Q9, Q10 and Q11 guidelines.

Define the Quality Target Product Profile

Translate patient and clinical needs into a QTPP that sets the design specification for the whole development programme, covering dosage form, strength, delivery and quality standards.

Identify Critical Quality Attributes

Determine which physical, chemical, biological and microbiological properties are critical to product quality, safety and efficacy, and classify them with confidence for both small molecules and biologics.

Run QbD Risk Assessments

Use Ishikawa (fishbone) diagrams and FMEA with RPN scoring to link material attributes and process parameters to each CQA, and prioritise the relationships that need experimental study.

Design and Interpret Experiments (DoE)

Plan screening and response-surface designs, interpret the statistical model output, and use it to define the design space, Normal Operating Ranges and Proven Acceptable Ranges.

Apply PAT and Build a Control Strategy

Use Process Analytical Technology and combine material, process and in-process controls into a risk-proportionate control strategy that keeps production within the design space.

Document QbD for Regulatory Submission

Structure the QTPP, risk assessment, design space and control strategy evidence for the pharmaceutical development section of a CTD submission to the FDA, EMA and ANMPS.

Who Should TakeQuality by Design Training in Tunisia?

Process Engineers

QC Analysts

Engineering Teams

Technical Staff

Production Managers

Distribution Managers

Regulatory Affairs Specialists

Quality Assurance Professionals

Who Can Take This Certification Training

Quality by Design Training Modesfor Professionals and Teams

We offer flexible training formats designed to suit different learning preferences, schedules, and professional goals. Whether you prefer self-paced learning or a structured, corporate, instructor-led experience, choose the option that best supports your skill development journey with the best Quality by Design online training options.

Quality by Design Classroom Training

Instructor-led classroom sessions
Interactive discussions and group activities
Real-world examples and practical exercises
Structured learning with fixed schedules
Opportunities for peer networking and collaboration
Practice assessments and knowledge checks
Dedicated Q&A and concept clarification
Immediate trainer feedback and support

Untitled

Learn through face-to-face sessions led by experienced instructors in a collaborative classroom environment. This classroom Quality by Design training combines expert guidance, peer interaction, and hands-on activities to create an engaging learning experience.

Untitled

Best For: Learners who prefer in-person interaction, structured schedules, and collaborative learning experiences.

Untitled

Quality by Design Live Virtual Training

Live online instructor-led sessions
Interactive discussions and virtual activities
Expert guidance from experienced trainers
Practice assessments and revision support
Dedicated Q&A sessions for concept clarification
Fixed schedules for accountability and momentum
Small batch sizes for personalized attention
Access from any location with internet connectivity

USD 395

Attend fully interactive weekday Quality by Design training sessions from anywhere while benefiting from real-time instructor guidance and collaborative learning experiences.

Untitled

Best For: Professionals seeking the flexibility of online learning without compromising on live instructor interaction.

Untitled

Quality by Design Corporate Group Training

Customized training aligned to organizational goals
Flexible delivery: onsite, virtual, hybrid, or blended
Scheduling tailored to business availability
Role-based examples and industry-relevant discussions
Progress tracking and learner assessments where applicable
Dedicated coordination and administrative support
Consistent learning experiences across teams
Scalable delivery for local, regional, or global workforces

Untitled

Designed for organizations that want to build capabilities at scale, standardize knowledge, and support workforce development through customized team learning initiatives.

Untitled

Best For: Organizations looking to upskill employees, address capability gaps, and deliver consistent training across teams.

Untitled

Quality by Design Focused 1-to-1 Training

One-to-one instructor attention
Customized learning plans and objectives
Flexible scheduling based on availability
Personalized feedback and coaching
Additional focus on challenging topics
Targeted practice and revision support
Faster clarification of questions and concepts
Learning pace is adapted to individual needs

Untitled

Receive personalized instruction tailored to your goals, pace, and learning requirements through dedicated sessions from our trusted Quality by Design training company.

Untitled

Best For: Professionals seeking personalized guidance, accelerated learning, or focused support to achieve specific outcomes.

Untitled

Quality by Design Classroom Training

Instructor-led classroom sessions

Interactive discussions and group activities

Real-world examples and practical exercises

Structured learning with fixed schedules

Opportunities for peer networking and collaboration

Practice assessments and knowledge checks

Dedicated Q&A and concept clarification

Immediate trainer feedback and support

Untitled

Please Note:Learn through face-to-face sessions led by experienced instructors in a collaborative classroom environment. This classroom Quality by Design training combines expert guidance, peer interaction, and hands-on activities to create an engaging learning experience.

Best For: Learners who prefer in-person interaction, structured schedules, and collaborative learning experiences.

Loading schedules…

Why Choose Invensis Learning for Quality by Design Training in TunisiaExpert-Led, Flexible and Practical

Invensis Learning delivers practical Quality by Design training for pharmaceutical professionals and organisations across Tunisia and worldwide. Our programmes combine experienced practitioner trainers, ICH-aligned courseware, flexible delivery formats and learner-focused support. Whether you enrol as an individual or arrange corporate training for your team, we focus on real understanding and workplace application, backed by ISO 9001:2015 and ISO 27001:2022 certified processes.

Experienced practitioner trainers in pharmaceutical quality and development
Live virtual, classroom and onsite delivery to fit working schedules
Hands-on exercises using realistic pharmaceutical development scenarios
ISO 9001:2015 certified quality and ISO 27001:2022 certified information security
Structured, ICH-aligned courseware focused on workplace application
Dedicated learner support before, during and after training
Customised corporate delivery for pharmaceutical teams in Tunisia
Global training provider trusted across more than 100 countries

5000+

Accredited Trainers Globally

4.7/5

Rated by Learners Worldwide

500+

Corporate Clients

15+

Years of Training Excellence

ISO 9001:2015 Certified

ISO 27001:2022 Certified

Secure SSL Encryption

Leaders in Training industry for 12+ years

Over 5000 five star reviews

Level AA conformance, W3C WCAG 2.2

Quality by Design Training Locations in TunisiaAll our classroom training is now available online at your convenience

Quality by Design in Tunisia

Mövenpick Hotel Du Lac Tunis, Great Salt Lake Pass, lakeside, lake, El Khadra delegation, Tunisia, Tunis Governorate, 1053, Tunisia

Quality by Design in Tunisia

Sheraton Tunis Hotel, Tunisia

Quality by Design in Tunisia

Mövenpick Hotel Du Lac Tunis, Great Salt Lake Pass, lakeside, lake, El Khadra delegation, Tunisia, Tunis Governorate, 1053, Tunisia

Quality by Design in Tunisia

Sheraton Tunis Hotel, Tunisia

Corporate QbD Training for Pharma TeamsAcross Tunisia

Untitled

Tailored QbD content mapped to your live development projects
Onsite, live virtual or blended delivery for teams
Schedules aligned to your production and project calendar
Cross-functional training across formulation, process, QA and regulatory
Experienced trainers with pharmaceutical industry expertise
Progress tracking and dedicated coordination for group training
Scalable delivery for single-site or multi-site organisations

What Our Learners Say

Untitled

A Practical New Way to Develop Products

"The QbD course completely changed how I approach formulation. I now start every project with a clear QTPP and CQA list, and the risk assessment tools helped me cut trial-and-error work on my last development batch."

Sana Ben Salah

Untitled

0/0

Finally Understand DoE and Design Space

"The Design of Experiments and design space sessions were exactly what I needed. I can now plan a screening study and read the response surface properly, instead of changing one factor at a time."

Yassine Trabelsi

Untitled

0/0

Clearer View of QbD in Submissions

"As a regulatory professional, the module on documenting QbD for the CTD was very useful. I understand far better what reviewers expect in the pharmaceutical development section and how the control strategy ties it together."

Mariem Gharbi

Untitled

0/0

Aligned Our Whole Team on QbD

"We booked this as onsite training for our development and quality teams. Everyone now shares the same QbD language, which has made our risk assessments and design reviews much faster and more consistent."

Khaled Bouazizi

Untitled

0/0

Relevant, Tailored and High Impact

"The trainer tailored the case studies to our biosimilar work, which made the content immediately relevant. Our people came away able to apply CQA identification and DoE to real projects. Strong return on the investment."

Ines Hammami

Untitled

0/0

4.6

Ratings

100K+

Happy Learners

100+

Locations Worldwide

99%

Training Satisfaction

Enquire with us now

Drop us a query and our learning consultant will reach out to you shortly

Get Course Details & Pricing

Fill out this form and we will respond quickly.

We also deliver Quality by Design Trainingacross multiple cities

Invensis Learning delivers industry-leading Quality by Design training solutions tailored for individuals and organizations.

Tunis

Explore Our Other Course Categories

Agile Certification Training Courses

Project Management Certification Training Courses

IT Service Management Certification Training Courses

Quality Management Certification Courses

DevOps Certification Training Courses

IT Governance Certification Training Courses

Other Related Courses

Foundation

Kaizen

Frequently Asked QuestionsHere's everything you may ask...

Quality by Design training is a practical course that teaches pharmaceutical professionals to build quality into products from the development stage. It covers the QbD approach set out in the ICH Q8, Q9, Q10 and Q11 guidelines, including the QTPP, Critical Quality Attributes, risk assessment, Design of Experiments, the design space and the control strategy.

General

What is Quality by Design training?

Is QbD training worth it for professionals in Tunisia?

Yes. As Tunisian manufacturers export to more than 20 markets and upgrade to European and WHO GMP standards, QbD skills are increasingly expected in development, quality and regulatory roles. The training gives you tools you can apply immediately to real pharmaceutical projects.

Which ICH guidelines does QbD training cover?

The course is aligned to the ICH quality guidelines: Q8(R2) Pharmaceutical Development, Q9 Quality Risk Management, Q10 Pharmaceutical Quality System and Q11 for drug substances. These form the regulatory foundation of Quality by Design worldwide.

Who should attend QbD training?

The course suits formulation scientists, process development engineers, analytical scientists, quality assurance professionals, regulatory affairs (CMC) specialists and manufacturing technical managers in pharmaceutical, biopharmaceutical, API, CDMO and medical device organisations.

Do I need prior QbD experience to attend?

No. The course has no formal prerequisites and introduces QbD from first principles. Familiarity with pharmaceutical development or GMP is helpful but not required.

Pricing

How much does QbD training cost in Tunisia?

Pricing depends on the delivery format (live virtual, classroom or corporate onsite) and group size. Fees include instructor-led training, ICH-aligned courseware, hands-on exercises and a course completion record. Contact us for current Tunisia pricing or request a group quote.

What is included in the course fee?

The fee typically includes live instructor-led training across all six QbD modules, ICH-aligned courseware, hands-on tool exercises, worked pharmaceutical case studies and a course completion record from Invensis Learning.

Do you offer corporate or group pricing?

Yes. We offer volume-based corporate pricing for pharmaceutical teams, with customised schedules and content mapped to your projects. Request a tailored quote for your organisation.

Are there discounts for training several team members?

Group and corporate rates are available when you train several team members together. Speak with a learning advisor to find the best option for your team.

What payment options are available?

We accept major credit and debit cards and bank transfers, with invoicing available for corporate bookings. Talk to our team to arrange payment for your enrolment.

Assessment

Is there an exam for QbD training?

No. This is a non-certification course with no examination. Learning is reinforced through hands-on QbD tool exercises, pharmaceutical case studies and group discussion during the programme.

What do I receive on completion?

You receive a course completion record from Invensis Learning confirming you have completed the Quality by Design programme. The skills are immediately applicable and do not expire.

How is learning checked during the course?

There is no formal assessment. Instead, you apply QbD tools such as the QTPP, CQA identification, risk assessment and design space interpretation to realistic development scenarios throughout the course.

Will I be able to apply QbD at work afterwards?

Yes. After the course you can construct a QTPP, identify and classify CQAs, run Ishikawa and FMEA risk assessments, plan DoE studies, interpret a design space and build a control strategy for submission.

Is QbD relevant to both small molecules and biologics?

Yes. The course covers QbD for small molecule drug products and for biopharmaceuticals such as monoclonal antibodies and biosimilars, with case examples drawn from both.

Course Content

What topics does QbD training cover?

The course covers six modules: QbD principles and the ICH framework; the QTPP and Critical Quality Attributes; risk assessment; Design of Experiments and the design space; Process Analytical Technology and the control strategy; and QbD in practice, including CTD submission and lifecycle management.

How long is the QbD training?

The programme runs for one day (8 hours), and can also be delivered as two half-day sessions. It covers the full QbD framework with hands-on exercises throughout.

Are there hands-on exercises?

Yes. You practise building a QTPP, identifying CQAs, constructing Ishikawa diagrams, selecting a DoE design and interpreting a design space, all using realistic pharmaceutical development scenarios.

What learning materials are provided?

You receive ICH-aligned courseware, worked pharmaceutical and biopharmaceutical case studies, QbD tool templates and reference material covering the ICH Q8, Q9, Q10 and Q11 guidelines.

Is the course aligned to current regulatory expectations?

Yes. The content reflects the ICH Q8(R2), Q9, Q10 and Q11 guidelines and current FDA and EMA expectations for QbD-based pharmaceutical development and control strategy.

Enrollment

How do I enrol in QbD training in Tunisia?

You can enrol through the Invensis Learning website or by contacting our team. Choose your preferred format, complete booking, and you will receive schedules, courseware and joining details. Talk to a learning advisor to pick a batch.

What delivery formats are available?

The course is available as live virtual (online) instructor-led training, in-person classroom training, and corporate onsite delivery for teams across Tunisia. Choose the format that suits your schedule.

Can the course be delivered onsite for my team?

Yes. We deliver corporate onsite QbD training at your premises, tailored to your live development projects, so cross-functional teams can learn and apply the tools together. Request a group quote to arrange this.

When are the next sessions scheduled?

New public and corporate sessions are scheduled regularly. Contact us or view upcoming schedules to find a date that fits, or arrange a dedicated session for your team.